Podcasts about Precision medicine

Welcome to Episode 270 of Autism Parenting Secrets.Parents are often overwhelmed by the flood of tests available—genetic tests, stool tests, organic acids tests, and more. Too often, the results create more confusion than clarity. This week, we're exploring a powerful new way to understand your child's biology: metabolomics. Unlike tests that only show potential risks or isolated snapshots, metabolomics reveals what's happening right now—the real-time state of your child's metabolism. My guest, Dr. Paniz Jasbi, Co-Founder and Chief Science Officer at Theriome, has pioneered a next-generation metabolomics test that turns complex biochemistry into clear, personalized insights for families and clinicians.The secret this week is… METABOLOMICS Reveals What Others Miss You'll Discover:What Exactly Is Metabolomics? (3:11)Why Genetics Alone Doesn't Tell the Full Story (7:32)How Metabolomics Validates What Parents Already Notice (14:10)How Theriome's Aristotle Test Stacks Up Against the Organic Acids Test (20:22)How Digital Twinning Pinpoints the Most Effective Actions (27:01)A Major Root Cause Seen in Children With Autism (40:56) About Our Guest:Paniz Jasbi, PhD, is the Co-Founder and Chief Science Officer at Theriome and a systems biologist specializing in mass-spectrometry–based metabolomics. He completed his PhD at Arizona State University, later serving as a Postdoctoral Research Scholar in the School of Molecular Sciences, and has authored peer-reviewed work linking metabolomic signatures to aging, neurocognition, and microbiome-related health. At Theriome, he leads development of the Aristotle Test, a next-generation metabolomics panel designed to translate complex biochemistry into practical, personalized recommendations for families and clinicians. Dr. Jasbi also serves as the Director of Metabolomics for the American Board of Precision Medicine.https://therio.meReferences In This Episode:Download a sample report and metabolomics guide: Theriome ResourcesAdditional Resources:To learn more about personalized 1:1 support, go to www.elevatehowyounavigate.comTake The Quiz: What's YOUR Top Autism Parenting Blindspot?If you enjoyed this episode, share it with your friends.

The new season of Business Class News's Race to the Start Line podcast launched with a conversation that was both deeply personal and profoundly forward-looking. Host Karl Woolfenden sat down with two leaders from Caris Life Sciences—Dr. David Spetzler, President and Chief Scientific Officer, and Dr. James Hamrick, Chairman of the Caris Precision Oncology Alliance —for a discussion on how Caris is transforming the future of cancer care. Woolfenden framed the conversation with personal reflections, sharing how recent losses in his own circle to cancer heightened his awareness of the need for innovation in oncology. “It tightened my awareness,” he said, “of how important it is to spotlight the companies and individuals driving meaningful progress.” Tackling the Complexity of Cancer Caris Life Sciences is a leader in molecular profiling and precision medicine, advancing how oncologists understand and treat cancer. Dr. Spetzler emphasized just how complicated this mission is: “Yeah, so I think what the patents demonstrate is that we're really on the cutting edge of trying to understand cancer. And the complexity of cancer is really quite staggering, because there are no two diseases that are the same.” He explained that Caris has built one of the world's largest datasets in cancer biology. “One of the things that we've been able to do is amass an enormous data set. We're approaching having profiled a million patients, and one of the great advantages that gives us is we can start to understand—from previous patients—new patients' status, and direct them towards the better drugs that are going to help them live longer.” From Science to the Patient Bedside Where Spetzler focused on the science, Dr. James Hamrick provided a clinical lens on the company's work. He reflected on his journey as both a practicing oncologist and now a leader at Caris. “The founder of Caris, and Dr. Spetzler who has been there since 2009, was always that connection point between the science and the patient. And that's where I focus—making sure what we're doing actually makes a difference in the clinic.” Hamrick highlighted the importance of ensuring that breakthroughs aren't confined to research institutions but are accessible to patients everywhere: “Too often, patients in community hospitals don't benefit from the latest advancements available at large academic medical centers. At Caris, we're working to close that gap.” Humanizing the Science The conversation underscored the human stakes of the work. Both leaders emphasized that the mission isn't just about data or discovery—it's about outcomes. Dr. Spetzler summed it up: “Science is only as valuable as the difference it makes in the real world. That's what drives us every day.” Scaling Innovation for the Future For Caris, growth means more than company expansion—it means scaling the reach of its technology so that physicians everywhere have the tools to personalize cancer care. This, Woolfenden pointed out, is a different kind of “race to the start line”: one where the finish line is measured in lives saved and futures extended. As the first episode in the series, the dialogue with Caris Life Sciences set a high standard for Race to the Start Line. It showcased how innovation, when combined with purpose, can shape industries—and in this case, save lives. 

The deficits from the lead poisoning continue to intensify, Shannon channels her anger and grief into holding the people who hurt her son responsible.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.EP4 features Eboni Booth, Sasha Eden, Kevin Kane, April Matthis, Alysia Reiner, and Mandy Siegfried. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The effects of the neurotoxin are taking their toll on Cooper as Shannon desperately tries to navigate the severity of their new reality.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.E43 features Jenny Maguire, JD Mollison, Laith Nakli, Deirdre O'Connell, Carolyn Baeumler, Zach Shaffer, and Monique Woodley. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of The Digital Executive podcast, host Brian Thomas sits down with Tracy Wood, CEO of The DNA Company, to explore how functional genomics is reshaping personalized healthcare. Tracy shares the powerful personal story of her sister's tragic passing that fueled her mission to reduce avoidable medical errors—one of the leading causes of death in the U.S. She discusses how pharmacogenomics (PGX) testing can prevent adverse drug reactions, reduce hospitalizations, and make precision medicine more accessible worldwide.With a focus on innovation, patient-centered care, and affordability, Tracy explains The DNA Company's groundbreaking approach to integrating genetic data, functional pathways, and patient history to deliver tailored health insights. She also highlights the company's commitment to ongoing research, expanding gene reports, and providing continuous updates through a unique mobile app—ensuring patients benefit from the latest science without the need for retesting.This conversation offers both a deeply personal perspective and a forward-looking vision of how functional genomics and precision medicine can save lives and transform healthcare globally.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In today's episode, you will hear an interesting English story. As you listen to the story, you will also learn a series of English terms that are connected to a specific topic. This lesson will help you improve your ability to speak English fluently about a specific topic. It will also help you feel more confident in your English abilities.Story Title“The Digital Lifeline”5 Vocabulary WordsTelemedicine: (noun) The remote delivery of healthcare services, such as diagnosis, consultation, and treatment.Example sentences: Telemedicine has become increasingly popular in recent years.Telemedicine appointments can be more convenient for patients.Telemedicine can help to reduce healthcare costs.Genetic Engineering: (noun) The deliberate modification of an organism's genome using genetic engineering techniques.Example sentences: Genetic engineering can be used to treat genetic diseases.Genetic engineering raises ethical concerns about the manipulation of life.Genetic engineering has the potential to improve crop yields and resistance to pests.Telehealth: (noun) The use of digital information and communication technologies to provide health care services.Example sentences: Telehealth can improve access to healthcare, especially in rural areas.Telehealth appointments can be more convenient and cost-effective for patients.Telehealth can be used for a variety of healthcare services, including mental health counseling and chronic disease management.Remote Patient Monitoring: (noun) The use of technology to monitor a patient's health status from a distance.Example sentences: Remote patient monitoring can help to prevent hospitalizations.Remote patient monitoring devices can track vital signs and other health metrics.Remote patient monitoring can improve patient outcomes and reduce healthcare costs.Precision Medicine: (noun) A form of medicine that uses information about a patient's genes, proteins, and environment to prevent, diagnose, and treat disease.Example sentences: Precision medicine can lead to more effective and personalized treatments.Precision medicine requires advanced genetic testing and analysis.Precision medicine has the potential to revolutionize healthcare.If you want to sign up for the free daily English vocabulary newsletter, go towww.dailyenglishvocabulary.com

Trauma isn't just in your mind—it can live in your body, shaping how your gut feels and functions.   On this episode of The Gut Show I talk to @drriehl from @theguthealthpodcast and we explore what trauma is, how it connects to IBS, feelings of hopelessness and options for treatment.    Mentioned in this episode:  Tailored to the Core: Breathing, Bloating and Precision Medicine: https://www.buzzsprout.com/2293918/episodes/17382514 Poop Personality Quiz: https://quiz.tryinteract.com/#/657789ba420624001409ca1a   MASTER Method Membership: https://www.ibsmastermethod.com/master-method     About our guest:  Dr. Megan Riehl, PsyD, AGAF is an Associate Professor of Medicine at the University of Michigan and a leading expert in psychogastroenterology. With a full-time clinical practice, she specializes in GI behavioral health, providing patient care, peer consultation, and professional training. Dr. Riehl also holds key leadership roles within Michigan Medicine focused on the area of wellbeing. A recognized thought leader, she serves on the national Board of Trustees for the Crohn's and Colitis Foundation. She is also the co-author of Mind Your Gut: The Science-Based, Whole-Body Guide to Living Well with IBS and co-host of The Gut Health Podcast alongside Kate Scarlata.   Mind Your Gut: https://amzn.to/3Ji96HB GI Psychology: www.gipsychology.com Psychology Today: www.psychologytoday.com  The Gut Health Podcast: https://theguthealthpodcast.buzzsprout.com     Thank you to our partners: This episode is made possible with support from Ardelyx. @gemellibiotech offers trusted, science-backed at-home tests for conditions like SIBO, IMO, ISO, and post-infectious IBS.  Their Trio-Smart breath test measures all three key gases: hydrogen, methane, and hydrogen sulfide to detect different forms of microbial overgrowth. And for those with IBS symptoms, IBS-Smart is a simple blood test that can confirm post-infectious IBS with clinical accuracy. You simply order the test, complete it at home, send it back, and get clinically backed results in about a week that you can take to your provider!  Find out which tests are right for you at getgutanswers.com and use code ERINJUDGE25 to save $35 on your order! @fodzyme is the world's first enzyme supplement specialized to target FODMAPs. When sprinkled on or mixed with high-FODMAP meals, FODZYME's novel patent-pending enzyme blend breaks down fructan, GOS and lactose before they can trigger bloating, gas and other digestive issues. With FODZYME, enjoy garlic, onion, wheat, Brussels sprouts, beans, dairy and more — worry free! Discover the power of FODZYME's digestive enzyme blend and eat the foods you love and miss. Visit fodzyme.com and save 20% off your first order with code THEGUTSHOW. One use per customer.    

As the lead wreaks havoc on Cooper's development, Shannon searches for answers. Desperate to get a handle on what was happening to her son, she grabs onto a lifeboat - nursing school. Andy tries to piece together the past to make sense of the present.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper BurkettEP2 features Keith Nobbs and Frank Wood. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Introducing Melissa Smith, PharmD, CPH, CPGx, Founder of Florida PGX Consulting, and the new host of the Precision Health and PGX Podcast! Dr. Melissa is joined by her guests Dr. Jamie Wilkey & Dr. Jackie Boyle to discuss their introduction to precision medicine in PGX, as well as their friendship that encouraged it!

Medicine stands at the threshold of a new era, where artificial intelligence and systems biology are working hand in hand to make care more personal, predictive, and precise than ever before. AI is already improving diagnostic accuracy, automating administrative tasks, and uncovering patterns in data—like retinal scans or genomics—that humans often miss. Rather than replacing doctors, AI enhances their ability to deliver more informed, precise, and efficient care. At the same time, individuals are gaining tools—from at-home diagnostics to wearable biosensors—that empower them to track and optimize their own health. This shift marks a move from reactive, disease-centered care to a proactive, data-driven model of scientific wellness. In this episode, I talk with Dr. Eric Topol, Dr. Nathan Price, Dr. Leroy Hood, Dr. Vijay Pande, and Daisy Wolf about how artificial intelligence, personalized data, and wearable technology are converging to radically transform medicine. Dr. Eric Topol is Executive Vice President of Scripps Research and founder/director of its Translational Institute, recognized as one of the top 10 most cited researchers in medicine with over 1,300 publications. A cardiologist and author of several bestselling books on the future of medicine, he leads major NIH grants in precision medicine and shares cutting-edge biomedical insights through his Ground Truths newsletter and podcast. Dr. Nathan Price is Chief Scientific Officer at Thorne HealthTech, author of The Age of Scientific Wellness, and a National Academy of Medicine Emerging Leader. He also serves on the Board on Life Sciences for the National Academies and is Affiliate Faculty in Bioengineering and Computer Science at the University of Washington. Dr. Leroy Hood is CEO and founder of Phenome Health, leading the Human Phenome Initiative to sequence and track the health of one million people over 10 years. A pioneer in systems biology and co-founder of 17 biotech companies, he is a recipient of the Lasker Prize, Kyoto Prize, and National Medal of Science. Dr. Vijay Pande is a General Partner at Andreessen Horowitz and founder of a16z Bio + Health, managing over $3 billion in life sciences and healthcare investments at the intersection of biology and AI. An Adjunct Professor at Stanford, he is known for his work in computational science, earning honors like the DeLano Prize and a Guinness World Record for Folding@Home. Daisy Wolf is an investing partner at Andreessen Horowitz, specializing in healthcare AI, consumer health, and healthcare-fintech innovation. She previously worked at Meta and in various startups, holds a JD from Yale Law, an MBA from Stanford, and a BA from Yale, and is based in New York City. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN10 to save 10%. Full-length episodes can be found here: Can AI Fix Our Health and Our Healthcare System? The Next Revolution In Medicine: Scientific Wellness, AI And Disease Reversal The Future of Healthcare: The Role of AI and Technology

In this episode of Onc Now, host Jonathan Sackier is joined by Simon Lord, Associate Professor in Experimental Cancer Therapeutics, University of Oxford, UK, to discuss translating scientific breakthroughs into real-world treatments. With deep expertise in precision medicine and a passion for innovation in oncology, Lord brings a unique perspective on how the future of cancer therapy is being shaped today.      Timestamps  01:04 – Quickfire question  11:26 – Metabolic imaging  15:26 – Insulin resistance  18:04 – Patient-specific biology  20:35 – Tamoxifen risks  21:57 – Metabolic interventions  24:46 – Lifestyle changes  27:04 – Clinical trials  00:00 – Wishes for healthcare 

In this episode, host Steve Lewis sits down with Giovanna Prout, President and CEO of Scale Biosciences, to explore how Scale is pushing the boundaries of single-cell omics. With a career that spans roles with big players and entrepreneurial ventures, Giovanna brings a unique perspective to the world of genomics innovation.Giovanna dives into Scale's patented Quantum Barcoding technology—a high-throughput, combinatorial indexing approach that allows researchers to process millions of cells and thousands of samples simultaneously, all without the need for specialized instrumentation. She explains how this flexible, automation-friendly platform is opening doors for AI-driven data modeling, large-scale drug screening, and highly diverse patient cohort studies.Beyond the science, Giovanna reflects on her leadership journey, emphasizing persistence, servant leadership, and a passion for making a difference in life sciences. She also shares the vision behind the 100 Million Cell Initiative, a bold collaboration that empowers scientists to dream big without constraints. For early-career scientists, Giovanna offers candid advice on working hard, staying curious, and believing in the impact of their work. Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

A mysterious dust fills a young family's apartment. The truth begins to unravel when the mother gets a call from the pediatrician - the monster deep within the walls has been unleashed. LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett. EP1 features Zak Orth, Jenny Maguire, Daphne Gaines, and Micheal Gaston. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Vonda Wright sits down with Dr. Catherine Johnson, a dual board-certified Emergency and Obesity Medicine physician and the visionary Founder of Precision Medical Care. With over 25 years of clinical experience and advanced training in precision and functional medicine, Dr. Johnson now leads a concierge practice focused on longevity, metabolic health, and hormone optimization. Together, they explore how medicine is evolving from reactive care to proactive, personalized precision health. Dr. Johnson shares how her practice uses in-depth data—biomarkers, genomics, and lifestyle patterns—to create tailored wellness plans. They discuss the power of a two-hour intake, the importance of understanding your own health trajectory, and how integrative care can restore trust in medicine. Special focus is given to women's health in midlife, from hormone balance to weight resistance and beyond. Dr. Johnson emphasizes empowerment through education and the potential of precision medicine to shift how we age—intentionally, energetically, and with purpose. Listen in for an inspiring conversation about the future of medicine and how women can take back agency over their health and longevity. ••• Connect with Dr. Catherine Johnson: Practice website: http://www.myprecisionmedicalcare.com Instagram: @catherinejohnsonmd, @precisionmedicalcare Twitter/X: @catjohnsonmd LinkedIn: http://www.linkedin.com/in/catherine-johnson-md-dabom-abem-mscp-217b184 ••• Make sure to follow Dr. Vonda Wright: Instagram: @drvondawright Youtube: https://www.youtube.com/@vondawright Tiktok: https://www.tiktok.com/@drvondawright LinkedIn: https://www.linkedin.com/in/vonda-wright-md-ms-2803374 Website: http://www.DrVondaWright.com ••• If you enjoyed this episode, Subscribe to “HOT For Your Health” for more inspiring episodes. Apple Podcast: https://podcasts.apple.com/us/podcast/hot-for-your-health/id1055206993 Spotify: https://open.spotify.com/show/1Q2Al27D79jCLAyzp4hKBv?si=b62b374994884eed We'd love to hear your thoughts on this episode! Share your comments or join the discussion on social media using #HotForYourHealthPodcast.

In this episode, Erwin Estigarribia, CEO, and Dr. Felice Sheh, Chief Business Officer of Headlamp Health, explore how AI and multimodal data are revolutionizing mental health treatment. They discuss the shift toward proactive, precision-based care and the importance of responsible AI use in improving outcomes and reducing trial-and-error approaches.This episode is sponsored by Headlamp Health.

Send us a text

Lexi Silver is 15 years old. She lost both of her parents before she turned 11. That should tell you enough—but it doesn't. Because Lexi isn't here for your pity. She's not a sob story. She's not a trauma statistic. She's a writer, an advocate, and one of the most emotionally intelligent people you'll ever hear speak into a microphone.In this episode, Lexi breaks down what grief actually feels like when you're a kid and the adults around you just don't get it. She talks about losing her mom on Christmas morning, her dad nine months later, how the system let her down, and how Instagram trolls tell her she's faking it for attention. She also explains why she writes, what Experience Camps gave her, how she channels anger into poems, and what to say—and not say—to someone grieving.Her life isn't a Netflix drama. But it should be.And by the way, she's not “so strong.” She's just human. You'll never forget this conversation.RELATED LINKS• Lexi on Instagram: @meet.my.grief• Buy her book: The Girl Behind Grief's Shadow• Experience CampsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if medicine worked to get you healthier overall—not just people like you or for one or another symptom? In the latest episode of TGen Talks, host Karie Dozer sits down with Nicholas Schork, Ph.D., and Laura Goetz, M.D., co-authors of a recent commentary published in Nature Communications, From Precision Interventions to Precision Health, to explore the promise—and complexity—of truly personalized healthcare. Traditional medicine treats symptoms. Precision healthcare, however, rethinks that model entirely. By tapping into genomics, environment, lifestyle, and even real-time data from wearable devices, Drs. Schork and Goetz discuss developing highly individualized approaches that don't just treat illness—they aim to prevent it. Together, they unpack how this shift could redefine everything from how drugs are tested, to how diseases are managed, and even how we define “health.” They discuss cutting-edge innovations like anti-sense oligonucleotides—drugs custom-made for an individual's genetic code—and the rise of geroprotectors, compounds designed to support whole-body wellness as we age. They discuss the difficulties of such specific treatments and the differences in the way different patients might metabolize and respond to the same medicine. The future of medicine isn't one-size-fits-all. It's N-of-1—and it might just be closer than you think.

Dr. Tracy Gapin is a renowned expert in men's health optimization and longevity with over 25 years of experience as a board-certified urologist. As the founder of the Gapin Institute for Precision Medicine, Dr. Gapin leverages his extensive background to help high-performing entrepreneurs, athletes, and executives reach their peak potential through cutting-edge, data-driven health strategies. He combines lifestyle medicine, functional medicine, epigenetics, hormone therapy, and regenerative medicine to help clients significantly enhance both their well-being and performancePlease learn more about Dr. Tracy Gapin at www.GapinInstitute.comIn this enlightening episode of Mr. Biz Radio, host Ken "Mr. Biz" Wentworth welcomes Dr. Tracy Gapin. Dr. Gapin shares his inspiring journey from a busy urologist to a trailblazer in proactive health management, empowering men to reclaim their vitality and long-term wellness. The conversation explores the pressing issue of neglected men's health and emphasizes the critical need for proactive rather than reactive medical strategies. Dr. Gapin provides actionable insights on how high-performing individuals can optimize energy, focus, and drive to achieve peak performance—both personally and professionally.Key Takeaways:-Men's health should be proactive, focusing on diagnostics and preventing illness rather than reacting once it occurs.-Comprehensive blood tests and other diagnostics provide actionable insights into health and can dramatically improve energy and focus.-Quality sleep is crucial for optimizing health, as it allows the body to repair and rejuvenate itself.-Utilize wearable tech like CGMs and rings to track metrics such as heart rate variability and sleep patterns for better health outcomes.-Understand that a one-size-fits-all strategy is ineffective; health optimization should be personalized based on individual biomarkers and lifestyle choices.

Michelle Andrews built a career inside the pharma machine long before anyone knew what “DTC” meant. She helped launch Rituxan and watched Allegra commercials teach America how to ask for pills by name. Then she landed in the cancer fun house herself, stage 4 breast cancer, and learned exactly how hollow all the “journey” slide decks feel when you're the one circling the drain.We talk about what happens when the insider becomes the customer, why pill organizers and wheat field brochures still piss her off, and how she fired doctors who couldn't handle her will to live. You'll hear about the dawn of pharma advertising, the pre-Google advocacy hustle, and what she wants every brand team to finally admit about patient experience.If you've ever wondered who decided windsurfing was the best way to sell allergy meds—or what happens when you stop caring if you make people uncomfortable—listen up.RELATED LINKSMichelle Andrews on LinkedInTrinity Life Sciences – Strategic AdvisoryJade Magazine – Ticking Time Bombs ArticleNIHCM Foundation – Breast Cancer StoryFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Onc Now, host Jonathan Sackier is joined by Jean Abraham, Professor of Precision Breast Cancer Medicine at the University of Cambridge, to delve into the future of integrated cancer medicine, the evolving role of clinical trials, and how precision oncology is redefining outcomes for patients with breast cancer across the UK.  Timestamps  00:00 – Introduction  01:28 – Quickfire round  09:50 – Cambridge institutes for precision medicine  12:53 – Predictive/prognostic tools in breast cancer  15:33 – The future of breast cancer clinical trials  18:34 – Integrating genomic data  22:31 – Addressing cost barriers  24:22 – How AI is transforming breast cancer care  28:08 – Why oncology?  30:04 – A message to non-oncologists  31:54 – Abraham's three wishes for healthcare  

Dr. Anne Marie Morse walks into the studio like a one-woman Jersey Broadway show and leaves behind the best damn TED Talk you've never heard. She's a neurologist, sleep medicine doc, narcolepsy expert, founder of D.A.M.M. Good Sleep, and full-time myth buster in a white coat. We talk about why sleep isn't a luxury, why your mattress does matter, and how melatonin is the new Flintstones vitamin with a marketing budget. We unpack the BS around sleep hygiene, blow up the medical gaslighting around “disorders,” and dig into how a former aspiring butterfly became one of the loudest voices for patient-centered science. Also: naps, kids, burnout, CPAPs, co-sleeping, airport pods, the DeLorean, and Carl Sagan. If you think you're getting by on five hours of sleep and vibes, you're not. This episode will make you want to take a nap—and then call your doctor.RELATED LINKSdammgoodsleep.com: https://www.dammgoodsleep.comLinkedIn: https://www.linkedin.com/in/anne-marie-morse-753b2821/Instagram: https://www.instagram.com/dammgoodsleepDocWire News Author Page: https://www.docwirenews.com/author/anne-marie-morseSleep Review Interview: https://sleepreviewmag.com/practice-management/marketing/word-of-mouth/sleep-advocacy-anne-marie-morse/Geisinger Bio: https://providers.geisinger.org/provider/anne-marie-morse/756868SWHR Profile: https://swhr.org/team/anne-marie-morse-do-faasm/FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Does personalized precision medicine have the potential to treat chronic and life-threatening diseases like cancer and enhance longevity? In this episode, we connect with Dr. John Oertle, the Chief Medical Director at Envita Medical Centers, to dive into the innovative field of personalized precision medicine – something that has played a critical role in helping many late-stage cancer patients recover holistically… Dr. Oertle specializes in chronic infectious disease, immunotherapy, and precision oncology. He leads the molecular tumor board for Envita Medical Centers and does research and development in the fields of oncology and infectious disease. Dr. Oertle and his team treat diseases by identifying and addressing the root causative factors, considering the detailed genetics, epigenetics, pharmacogenomics, environmental, and other factors that contribute to patient recovery.  Want to learn how this level of in-depth analysis can help build a customized treatment protocol for each individual patient? What does it mean to go beyond the standard one-size-fits-all protocols? Join the conversation now to find out!  Hit play to discover: ●      Why focusing on outcomes is so critical to effectively treating chronic diseases. ●      The benefits of providing individualized cancer therapy.  ●      How to teach the immune system to attack harmful tumors.  ●      The role that biological age plays in disease prevention and recovery. Click here to follow along with Dr. Oertle and his important work at Envita Medical Centers!

Kurt Lunkwitz, Chief Operating Officer at ProRx Pharma, describes the role compound pharmacies play in filling gaps when certain drugs are in short supply and providing personalized medications for patients. Compound pharmacies offer a wide range of customized formulations and delivery methods to meet the specific needs of patients, particularly in the areas of functional and preventative medicines. These pharmacies are enabling a shift towards precision medicine and individualized care, responding to the market demand for alternative and preferred formulations of medications.  Kurt explains, "There's primary clientele and then there's secondary clientele. Our primary clientele includes a host of prescribers, medical clinics, and could be telemedicine-type companies, and med spas. There are tens of thousands of these types of practitioner offices across the country, and it's a wide and booming industry as it relates to functional medicine, alternative medicine, or as we like to refer to it, preventative care. And the secondary customer would be the patient themselves. So the medications that ProRx is compounding would be ordered through these physicians' offices, these practices, and for their particular patient and customer base." "One of the primary functions in the role of a 503 B outsourcing facility, or a number of them across the country, is to step in and fill this gap. If the primary manufacturer, the pharmaceutical manufacturer, has a disruption in the supply chain, or simply just can't keep up with the demand." "If we want to take a look at one of the largest supply chain gaps that has existed, and it's been a very popular topic of conversation here more recently, this would relate a lot to some of the GLP-1 medications, both semaglutide and tirzepatide. So these were two medications that ProRx participated in and helped to fill the shortage gap. There were a handful of months where ProRx went into production, and we helped to fill tens of thousands of prescriptions for patients of medical necessity who badly needed these medications."  #ProRxPharma #CompoundPharmacy #DrugShortageList  prorxpharma.com Download the transcript here

Kurt Lunkwitz, Chief Operating Officer at ProRx Pharma, describes the role compound pharmacies play in filling gaps when certain drugs are in short supply and providing personalized medications for patients. Compound pharmacies offer a wide range of customized formulations and delivery methods to meet the specific needs of patients, particularly in the areas of functional and preventative medicines. These pharmacies are enabling a shift towards precision medicine and individualized care, responding to the market demand for alternative and preferred formulations of medications.  Kurt explains, "There's primary clientele and then there's secondary clientele. Our primary clientele includes a host of prescribers, medical clinics, and could be telemedicine-type companies, and med spas. There are tens of thousands of these types of practitioner offices across the country, and it's a wide and booming industry as it relates to functional medicine, alternative medicine, or as we like to refer to it, preventative care. And the secondary customer would be the patient themselves. So the medications that ProRx is compounding would be ordered through these physicians' offices, these practices, and for their particular patient and customer base." "One of the primary functions in the role of a 503 B outsourcing facility, or a number of them across the country, is to step in and fill this gap. If the primary manufacturer, the pharmaceutical manufacturer, has a disruption in the supply chain, or simply just can't keep up with the demand." "If we want to take a look at one of the largest supply chain gaps that has existed, and it's been a very popular topic of conversation here more recently, this would relate a lot to some of the GLP-1 medications, both semaglutide and tirzepatide. So these were two medications that ProRx participated in and helped to fill the shortage gap. There were a handful of months where ProRx went into production, and we helped to fill tens of thousands of prescriptions for patients of medical necessity who badly needed these medications."  #ProRxPharma #CompoundPharmacy #DrugShortageList  prorxpharma.com Listen to the podcast here

What does it really mean to bring precision medicine to every patient, in every community?In this inspiring, one-hour episode of the Precision Medicine Podcast, host Karan Cushman sits down with Dr. Arif Kamal, Chief Patient Officer at the American Cancer Society (ACS), for a wide-ranging conversation that reframes how we think about progress in cancer care. With a background in oncology, palliative care and health system innovation—and a personal story shaped by his mother's metastatic breast cancer diagnosis—Dr. Kamal offers a deeply human perspective on what it means to deliver not just the right treatment, but the right experience for every patient.Dr. Kamal shares how the ACS is working to make precision medicine more equitable by addressing barriers like geography, affordability, clinician burnout, and fragmented care. He explains the importance of “precision compassion”—the idea that personalized care must also include empathy, listening, and action tailored to the needs of each individual. “We can't talk about innovation,” he says, “without talking about accessibility.”From the importance of whole-person care and mobile health units in rural communities, to expanding insurance coverage for biomarker testing and building trust with patients and caregivers, this conversation is full of insight into what it will truly take to change the odds for people facing cancer.You'll also hear about the ACS's bold initiatives:The Change the Odds campaign, tackling ZIP code-driven disparities in careACS CAN's legislative efforts to expand access to biomarker testingHow the ACS's roundtables and grassroots partnerships support health systems, clinicians, and researchers nationwideDr. Kamal challenges us to think beyond science alone and focus on what really matters to patients—whether that's more time, better quality of life or simply the ability to hold a grandchild on the beach.Don't miss this conversation about how we turn precision medicine from a possibility into a promise—one rooted in empathy, equity and action.Subscribe here to catch every episode in the series "Bringing Precision Medicine to Everyone." Next, we explore the evolving world of liquid biopsy and its role in expanding access to early cancer detection and precision treatment.

Gigi Robinson grew up with Ehlers-Danlos syndrome, a disease that turns your joints into overcooked spaghetti. Instead of letting it sideline her, she built a career out of telling the truth about invisible illness. We talk about what it takes to grow up faster than you should, why chronic illness is the worst unpaid internship, and how she turned her story into a business. You'll hear about her days schlepping to physical therapy before sunrise, documenting the sterile absurdity of waiting rooms, and finding purpose in the mess. Gigi's not interested in pity or polished narratives. She wants you to see what resilience really looks like, even when it's ugly. If you think you know what an influencer does, think again. This conversation will challenge your assumptions about work, health, and what it means to be seen.RELATED LINKSGigi Robinson Website: https://www.gigirobinson.comLinkedIn: https://www.linkedin.com/in/gigirobinsonInstagram: https://www.instagram.com/itsgigirobinsonTikTok: @itsgigirobinsonA Kids Book About Chronic Illness: https://akidsco.com/products/a-kids-book-about-chronic-illnessFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This episode features Dr. James Lu, CEO and Co-founder of Helix, discussing how precision medicine is evolving from specialty use to becoming a foundational element of mainstream healthcare. He explores the infrastructure, partnerships, and mindset shifts needed for health systems to scale genomic data and realize its full value.This episode is sponsored by Helix.

In this insightful interview with Blue Box Asset Mangement's Porfolio Manager Mark Dainty we talk about precision medicine and life sciences, his investment strategy, and how he constructs a portfolio of "developers" vs "enablers". We also talk about 3 stocks in the fund. We hope you enjoy listening!  *~*~*~*~*  Get access to all of Speedwell Research's in-depth Research Reports here. If you need help getting Speedwell added as an approved research vendor for your investment firm, please reach out to info@speedwellresearch.com  -*-*-*-*-*-*-*-*-*-*- Show Notes (0:00) — What is Precision Medicine and Life Sciences (11:15) — Small Markets, but Higher Prices (22:24) — Why Precision Medicine is like Dating Apps (27:56) — Investment Strategy and Portfolio Construction (47:20) — Two Stocks: Natera ($NTRA) and Guardant Health ($GH) (54:24) — Risk of the Unknown? (1:02:55) — Revolutions Medicines ($RVMD) (1:11:10) — Financial Modeling -*-*-*-*-*-*-*-*-*-*- Become a Speedwell Member here to gain access to *all* of our in-depth research reports and more!   Sign up for Speedwell's free newsletter and weekly memos here *~*~*~*~*  Follow Us: Twitter: @Speedwell_LLC Threads: @speedwell_research Email us at info@speedwellresearch.com for any questions, comments, or feedback. -*-*-*-*-*-*-*-*-*-*- Disclaimer Nothing in this podcast is investment advice nor should be construed as such. Contributors to the podcast may own securities discussed. Furthermore, accounts contributors advise on may also have positions in companies discussed. Please see our full disclaimers here:  https://speedwellresearch.com/disclaimer/

I'm beyond excited to share our latest podcast episode with you. This time, I had the pleasure of chatting with the incredible Maddi Holman, the general partner of Daring Ventures and the host of her own podcast, "Let's Be Heard." Maddi's journey from aspiring doctor to venture capitalist is nothing short of inspiring, and I can't wait for you to hear her story.Here are some of the key takeaways and intriguing insights from our conversation:

In this episode of BioTalk, Rich Bendis welcomes Dr. Helen Sabzevari, President and CEO of Precigen, to discuss the company's cutting-edge science in gene and cell therapy. Dr. Sabzevari shares how Precigen's unique AdenoVerse® platform has powered the development of PRGN-2012, a potential first-in-class therapeutic currently under FDA priority review for the treatment of adults with recurrent respiratory papillomatosis (RRP), a rare and devastating disease. She also highlights advances across Precigen's broader pipeline in immuno-oncology and autoimmune disease and reflects on how Maryland's BioHealth Capital Region has supported the company's innovation and growth.   Editing and post-production work for this episode was provided by The Podcast Consultant.   Dr. Helen Sabzevari is the President and CEO of Precigen, Inc., and a leading expert in immunotherapy-based therapeutics. She previously served in executive roles at Compass Therapeutics and Merck KGaA/EMD Serono, where she advanced numerous immuno-oncology programs. Dr. Sabzevari began her career at the National Cancer Institute and has been widely recognized for her leadership and scientific contributions, including honors from NIH, SITC, and Forbes.

Episode Description:If you've ever wondered what happens when a Bronx-born pediatric nurse with stage 4 colon cancer survives, raises a kid, becomes a policy shark, and fights like hell for the ignored, meet Vanessa Ghigliotty. She's not inspirational. She's a bulldozer. We go way back—like pre-Stupid Cancer back—when there was no “young adult cancer movement,” just a handful of pissed-off survivors building something out of nothing. This episode is personal. Vanessa and I built the plane while flying it. She fought to be heard, showed up in chemo dragging her kid to IEP meetings, and never stopped screaming for the rest of us to get what we needed. We talk war stories, progress, side-eyeing advocacy fads, TikTok activism, gatekeeping, policy wins, and why being loud is still necessary. And yeah—she's a damn good mom. Probably a better one than you. You'll laugh. You'll cry. You'll want to scream into a pillow. Come for the nostalgia. Stay for the righteous anger and iced coffee.RELATED LINKSVanessa on LinkedInColorectal Cancer Alliance: Vanessa's StoryZenOnco Interview with VanessaFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Iris Wang of the Mayo Clinic shares cutting-edge insights on gut health across the lifespan, including advancements in pharmacogenomics for personalized medication selection and innovative breathing techniques to relieve abdominal distension. She busts common myths about bloating, revealing how diaphragmatic dysfunction rather than excess gas may be the culprit. Dr. Wang also emphasizes the importance of starting gut health education early, helping kids and parents alike understand that pooping shouldn't be painful or forced. • How pharmacogenomics helps identify why some patients metabolize medications differently, leading to better medication choices with exploration on the hope and/or hype of precision medicine in the GI world (Wang et al 2019)• Explanation of abdomino-phrenic dyssynergia (APD) – when the diaphragm moves downward instead of upward, causing visible abdominal distention• Specialized breathing technique developed in Barcelona that retrain the diaphragm for bloating relief (Barba E et al 2024) - see video link below• The importance of normalizing healthy pooping habits from childhood through education & tools like toileting stools (e.g. Squatty Potty)• Warning signs for parents about childhood constipation – including stool leakage, straining, & urinary problems (Tran DL et al 2023)• How yoga can support gut health through mindful movement, core engagement, & stress reductionYoga videos:Yoga For Digestion Flow| Yoga With Adriene (26 mins)Yoga for Bloating, Digestion, Ulcerative Colitis, IBD & IBS (12 mins)Check out Dr. Wang's children's book Boo Can't Poo, which helps normalize healthy pooping habits for kids while educating parents too.References:Wang XJ, Camilleri M. Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy. World J Gastroenterol. 2019 Mar 14;25(10):1185-1196.Barba E, Livovsky DM, Accarino A, Azpiroz F. Thoracoabdominal Wall Motion-Guided Biofeedback Treatment of Abdominal Distention: A Randomized Placebo-Controlled Trial. Gastroenterology. 2024;167(3):538-546.e1.Specialized breathing technique for abdominal distention: Video DemonstrationTran DL, Sintusek P. Functional constipation in children: What physicians should know. World J Gastroenterol. 2023 Feb 28;29(8):1261-1288.Learn more about Kate and Dr. Riehl:Website: www.katescarlata.com and www.drriehl.comInstagram: @katescarlata @drriehl and @theguthealthpodcastOrder Kate and Dr. Riehl's book, Mind Your Gut: The Science-Based, Whole-body Guide to Living Well with IBS. The information included in this podcast is not a substitute for professional medical advice, examination, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider before starting any new treatment or making changes to existing treatment.

This is not your average health conversation. Dr. Anil Bajnath joins me to decode the exposome—the totality of your lifelong exposures—and how it's quietly shaping your energy, mood, resilience, and even your future disease risk. We explore how deep data from multi‑omics testing can translate into practical steps for healing, from detox pathways and mitochondrial support to the balance between rigorous science and joy-driven living.We talk through everything from electric grounding and photobiomodulation to parenting as a longevity stressor, and how the body's “biological 401(k)” can be optimized with personalized strategies. This episode bridges ancient wisdom, futuristic science, and the very human art of transformation. Tune in for a mind-expanding look at what it means to truly know your body—and how to honor it in the most intelligent way possible.HIGHLIGHTS[00:00] - Why understanding the exposome is essential to personalized medicine[02:13] - From microbiology to multi-omics: Dr. Bajnath's origin story[06:52] - What is multi-omics? A breakdown of genomics, proteomics, microbiomics, and more[09:16] - How your environment and genetics interact to create disease—or resilience[15:53] - Why detox pathways matter more than you think[18:32] - The paradox of biohacking: when “clean living” isn't enough[24:33] - The power of grounding, electric charge, and frequency on cellular health[30:53] - A real-world case study: glyphosate exposure and recovery[35:59] - Integrating science, intuition, and technology in modern medicine[41:41] - Red blood cells, zeta potential, and PEMF therapy—explained[46:12] - The top 5 omics tests to build your personal health roadmap[52:08] - How parenting impacts longevity and what to do about it[57:44] - Big visions: democratizing access to precision health worldwideLINKS & RESOURCESDr. Anil Bajnath https://anilbajnath.comThe Institute for Human Optimizationhttps://ifho.orgUpgrade Your WellnessBEAM Minerals: http://beamminerals.com/beautifullybrokenUse code beautifullybroken for 20% offFlowpresso: https://calendly.com/freddiekimmel/flowpresso-one-on-one-discoverySilver Biotics Wound Healing Gel: https://bit.ly/3JnxyDD30% off Use Code: BEAUTIFULLYBROKEN for DiscountStemRegen: https://www.stemregen.co/products/stemregen?_ef_transaction_id=&oid=1&affid=52Code: beautifullybrokenLightPathLED: https://lightpathled.pxf.io/c/3438432/2059835/25794code: beautifullybroken CONNECT WITH FREDDIECheck out my website and store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/beautifullybroken.world/) YouTube: (https://www.youtube.com/@BeautifullyBrokenWorld)

Still trying to optimize your health with guesswork and generic advice?Most people settle for “one-size-fits-all” supplements and hope for the best-missing out on the breakthroughs that only real data and personalization can offer.In a world flooded with empty promises, few realize how quickly tailored, science-backed solutions can transform energy, focus, and longevity.Enter Vadim Fedotov—ex-pro athlete, CEO, and co-founder of Bioniq, the health tech company bringing truly personalized care to the world's top leaders, innovators, and athletes.In this eye-opening conversation, Vadim reveals why your biology is as unique as your fingerprint—and why the future belongs to those who personalize, measure, and adapt.Discover the systems, mindsets, and science behind optimizing human potential—without wasting time, money, or hope on outdated approaches.

Risa Arin doesn't just talk about health literacy. She built the damn platform. As founder and CEO of XpertPatient.com (yes, expert with no E), Risa's taking a wrecking ball to how cancer education is delivered. A Cornell alum, cancer caregiver, and ex-agency insider who once sold Doritos to teens, she now applies that same marketing muscle to helping patients actually understand the garbage fire that is our healthcare system. We talk about why she left the “complacent social safety” of agency life, how her mom unknowingly used her own site during treatment, what it's like to pitch cancer education after someone pitches warm cookies, and why healthcare should come with a map, a translator, and a refund policy. Risa brings data, chutzpah, and Murphy Brown energy to the conversation—and you'll leave smarter, angrier, and maybe even a little more hopeful.RELATED LINKS• XpertPatient.com• Risa Arin on LinkedIn• XpertPatient & Antidote Partnership• XpertPatient Featured on KTLA• 2024 Health Award BioFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Breast cancer is one of the most talked-about health issues in the world, but there's still so much we don't discuss. While mammograms and early detection campaigns have saved countless lives, the conversation often stops there.  What's missing is a deeper look at the lifestyle, genetic, and environmental factors that play a pivotal role in prevention, and the small, daily changes that can make a massive impact. Because here's the truth: 80% of breast cancer cases are not inherited. They're environmental. That means we have far more power than we think. But to tap into it, we need better guidance, smarter screening strategies, and a stronger understanding of how our bodies work. What kind of screenings should women get? How do factors like breast tissue increase the risk of breast cancer? In this episode, I'm joined by Dr. Pamela Smith, an internationally recognized functional medicine physician, author of 14 bestselling books, and co-director of the Personalized Medicine Certification at the University of South Florida.  She shares science-backed strategies to reduce your risk, strengthen your immune system, and support your body before and after a diagnosis. Things You'll Learn In This Episode  The 3 things that feed cancer Sugar, stress, and toxins are the trifecta that fuel cancer cell growth. But how do you realistically cut them out and what's secretly making them worse? Why 80% of breast cancer isn't genetic Family history matters but not as much as your environment. Which everyday exposures and habits have the biggest impact on your risk? The truth about hormones and alcohol Is hormone therapy safe? And what happens when you mix it with alcohol?  What most women don't know about screening Dense breast tissue, faulty methylation, even your gut health can affect your screening results. How do you make sure you're getting the full picture of your health?   Guest Bio Pamela Wartian Smith, M.D., MPH, MS is an internationally known speaker and author on the subject of Anti-Aging and Precision Medicine. She spent her first twenty years of practice as an emergency room physician with the Detroit Medical Center in a level 1 trauma center and then 28 years as an Anti-Aging/Functional Medicine specialist. She is a diplomat of the Board of the American Academy of Anti-Aging Physicians and is. Dr. Smith also holds a master's degree in public health and a master's degree in metabolic and nutritional medicine. She is in private practice and is the senior partner for The Center for Precision Medicine, with offices in Michigan and Florida. She has been featured on CNN, PBS, and many other television networks, has been interviewed in numerous consumer magazines, and has hosted two of her own radio shows. Dr. Smith was one of the featured physicians on the PBS series “The Embrace of Aging” as well as the online medical series “Awakening from Alzheimer's” and “Regain Your Brain”. She is the author of fourteen best-selling books, including How to Prevent Breast Cancer- Before & After: A Guide to Taking Back Control of Your Life. To learn more about Dr. Smith and to get her books, visit https://mdpamelasmith.com/.    About Your Host Hosted by Dr. Deepa Grandon, MD MBA, triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidenced-based lifestyle medicine.     ​​ Resources Feeling stuck and want guidance on how to transform your spiritual, mental and physical well being? Get access to Dr Deepa's 6 Pillars of Health video! Visit drdeepa-tlc.org to subscribe and watch the video for free. ‌ Work with Me Ready to explore a personalized wellness journey with Dr. Deepa? Visit drdeepa-tlc.org and click on “Work with Me” to schedule a free intake call. Together, we'll see if this exclusive program aligns with your needs!  Want to receive a devotional every week From Dr. Deepa? Devotionals are dedicated to providing you with a moment of reflection, inspiration, and spiritual growth each week, delivered right to your inbox. Visit https://www.drdeepa-tlc.org/devotional-opt-in to subscribe for free. Ready to deepen your understanding of trauma and kick start your healing journey? Explore a range of online and onsite courses designed to equip you with practical and affordable tools. From counselors, ministry leaders, and educators to couples, parents and individuals seeking help for themselves, there's a powerful course for everyone. Browse all the courses now to start your journey.   ​​TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced. Check out this episode on our website, Apple Podcasts, or Spotify, and don't forget to leave a review if you like what you heard. Your review feeds the algorithm so our show reaches more people. Thank you!

Dr. Jamie Wells is back—and this time, she brought a book. We cover everything from biomedical design screwups to the glorified billing software known as the EHR. Jamie's new book, A Clinical Lens on Pediatric Engineering, is a masterclass in what happens when you stop treating kids like small, drunk adults and start designing medicine around actual human factors. We talk about AI in pediatric radiology, why drug repurposing might save lives faster than biotech IPOs, and the absurdity of thinking one-size-fits-all in healthcare still works.Jamie's a former physician, a health policy disruptor, a bioethicist, an MIT director, and a recovering adjunct professor. She's also a unicorn. We dig into the wonk, throw shade at bad design, and channel our inner Lisa Simpsons. This one's for anyone who ever wondered why kids' hospitals feel like hell and why “make it taste like bubblegum” might be the most important clinical innovation of all time. You'll laugh, you'll learn, and you might get angry enough to fix something.RELATED LINKSJamie Wells on LinkedInBook: A Clinical Lens on Pediatric Engineering (Amazon)Book on SpringerDrexel BioMed ProfileGlobal Blockchain Business CouncilJamie's HuffPost ArticlesFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Erica Campbell walked away from corporate life, took a hard left from the British Embassy, and found her calling writing checks for families nobody else sees. As Executive Director of Pinky Swear Foundation, she doesn't waste time on fluff. Her team pays rent, fills gas tanks, and gives sick kids' parents the one thing they don't have—time. Then, breast cancer hit her. She became the patient. Wrote a book about it. Didn't sugarcoat a damn thing. We talk about parking fees, grief, nonprofit burnout, and how the hell you decide which families get help and which don't. Also: AOL handles, John Hughes, and letters from strangers that make you cry. Erica is part Punky Brewster, part Rosie the Robot, and part Lisa Simpson—with just enough GenX Long Island sarcasm to make it all land. This one sticks.RELATED LINKSPinky Swear FoundationThe Mastectomy I Always Wanted (Book)Erica on LinkedInThink & Link: Erica Campbell“Like the Tale of a Starfish” - Blog Post“Cancer Diagnosis, Messy Life, Financial Support” - Blog PostFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Allyson with a Y. Ocean with two Ls. And zero chill when it comes to changing the face of cancer care. Dr. Allyson Ocean has been quietly—loudly—at the center of every major cancer breakthrough, nonprofit board, and science-backed gut punch you didn't know you needed to hear. In this episode, she joins me in-studio for a conversation two decades in the making. We talk twin life, genetics, mitochondrial disease, and why she skipped the Doublemint Twins commercial but still ended up as one of the most recognizable forces in oncology. We cover her nonprofit hits, from Michael's Mission to Let's Win Pancreatic Cancer to launching the American Jewish Medical Association—yes, that's a thing now. We get personal about compassion in medicine, burnout, bad food science, and microplastics in your blood. She also drops the kind of wisdom only someone with her résumé and sarcasm can. It's raw. It's real. It's the kind of conversation we should've had 20 years ago—but better late than never.RELATED LINKS:– Dr. Allyson Ocean on LinkedIn– Let's Win Pancreatic Cancer– NovoCure Leadership Page– Michael's Mission– American Jewish Medical Association– The POLG Foundation– Cancer Buddy App (Bone Marrow and Cancer Foundation)– Dr. Ocean at OncLiveFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today we have Dr. Michael A. Schmidt, the founder, CEO, and Chief Scientific Officer of Sovaris Aerospace, a company focused on assessments and solutions applied to humans in space and extreme environments on Earth.  Michael is also a professor of aerospace medicine at the University of Central Florida College of Medicine, one of the few programs in the U.S. that offers a medical residency in aerospace medicine. Michael is known for his work pioneering the field of precision medicine. He uses molecular analytics, coupled with physiologic and behavioral assessments, to facilitate human performance and resilience on Earth as well as in the extreme environment of space. His work covers a spectrum from NASA, the NFL, the NBA, U.S. Olympic teams, Nike, SpaceX, Axiom Space, NASCAR, Special Operations, the Naval Submarine Medical Research Lab, the Mayo Clinic, and others. We had a long and fascinating conversation with Michael and decided to break the interview into two parts. This episode focuses on Michael's background and the cognitive and physical challenges astronauts experience in spaceflight. We also dive into the many ways that precision medicine is facilitating human performance and resilience here on Earth. In part two of our conversation, Michael talks about his work with NASA and SpaceX on the challenges of civilian spaceflight and the future of Mars exploration, including the construction of permanent colonies on the Moon and Mars. You won't want to miss that conversation. Show notes: [00:03:59] Dawn opens our interview mentioning that Michael grew up in Minnesota in a small farming community, asking if it's true that he sometimes had to do chores in 20- to 30-degree weather. [00:06:50] Dawn asks if it is true that Michael fell in love with science at a young age, even building telescopes at the age of 11. [00:08:00] Dawn asks Michael what it was that led him to become so fascinated with space specifically. [00:08:58] Dawn asks if Michael ever thought about becoming an astronaut. [00:10:09] Ken asks if it is true that Michael was a big reader as a child. [00:11:21] Dawn asks Michael to talk about his childhood athletic interests. [00:11:55] Dawn asks how it was that a high school quarterback from a small town in Minnesota ended up at university in the United Kingdom. [00:13:38] Ken asks Michael what years he worked at NASA Ames Research Center. [00:14:51] Ken mentions that when Michael was at NASA Ames, he did work collecting molecular and physiologic assessments of humans using NASA's 20-G centrifuge. Ken asks Michael to talk about the centrifuge and how he used it in his studies of hypergravity. [00:17:49] Ken comments on the fact that pieces of equipment like NASA's 20-G centrifuge are a precious scientific resource, and when they cease functioning, unfortunately, they are unlikely to be replaced. [00:19:40] Ken and Michael discuss the fact that microgravity, despite being one of the most pressing effects on astronaut health, is the one of the least addressed problems in human spaceflight. [00:21:48] Ken explains that Michael is the founder, CEO and Chief Scientific Officer of a company called Sovaris Aerospace, which is focused on assessments and solutions applied to humans in space and extreme environments on Earth. Ken asks Michael where the idea came from to found this company. [00:24:35] Dawn explains that since the human genome was first sequenced, there has been an acceleration of genome-based technologies that have made it possible to consider a person's genetic makeup, both in healthcare and optimizing performance. Dawn asks Michael to talk about the work he does applying genomics to human spaceflight. [00:28:52] Dawn asks about Michael's direction of the molecular profiling and precision medicine efforts for the Golden State Warriors during their record-breaking 73-9 season [00:32:57] Dawn mentions that Michael published a review in the journal Meta...